Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis
NCT03855956
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Early Cirrhosis
Interventions
OTHER:
KB174
OTHER:
Maltodextrin
Sponsor
Kaleido Biosciences